Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells.

Ma, Ling-di; Zhou, Min; Wen, Shi-hong; Ni, Cheng; Jiang, Li-jia; Fan, Jing; Xia, Lei

Ma, Ling-di; Zhou, Min; Wen, Shi-hong; Ni, Cheng; Jiang, Li-jia; Fan, Jing; Xia, Lei.

Affiliation

Ma LD; Center Laboratory, Second Changzhou People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, China. lingdimawsh@126.com

Leuk Lymphoma ; 51(7): 1326-36, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20497005

Subject(s)

Apoptosis; Cell Proliferation; Gene Silencing; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology; STAT3 Transcription Factor/genetics; Blotting, Western; Cell Cycle; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism; RNA, Messenger/genetics; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor/antagonists & inhibitors; STAT3 Transcription Factor/metabolism; Tumor Cells, Cultured

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Apoptosis / Gene Silencing / Cell Proliferation / STAT3 Transcription Factor Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2010 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google